drugset / Trial / NCT03866200
Resveratrol Trial for Relief of Pain in Pseudoachondroplasia
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to determine if self-administered oral resveratrol can dampen joint pain for individuals with pseudoachondroplasia compared to placebo. Another goal of this study is to evaluate side effects in this population.
Timeline
- Start
- 2019-06-29
- Primary completion
- 2020-10-28
- Completion
- 2020-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Resveratrol | Small molecule | 5 ml | Oral |
| Subject | Resveratrol | Small molecule | 125 mg | Oral |